Sentinel lymph node biopsy for breast cancer: Indications, contraindications, and new directions

Journal of Surgical Oncology

Volumn 95, Issue 6, 2007, Pages 440-442

  Cody III, Hiram S ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ASPIRATION BIOPSY; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; DUCTAL CARCINOMA IN SITU; EDITORIAL; HUMAN; LYMPHADENECTOMY; LYMPHATIC DRAINAGE; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR VOLUME;

AXILLA; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; SENTINEL LYMPH NODE BIOPSY;

EID: 34248217675     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20652     Document Type: Editorial

References (17)

1. Kim T, Giuliano AE, Lyman GH: Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 2006;106:4-16.
2. Naik AM, Fey J, Gemignani M, et al.: The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: A follow-up study of 4008 procedures. Ann Surg 2004;240:462-468.
3. Veronesi U, Paganelli G, Viale G, et al.: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-553.
4. Clarke D, Newcombe RG, Mansel RE: The learning curve in sentinel node biopsy: The ALMANAC experience. Ann Surg Oncol 2004;11:211S-215S.
5. McMasters KM, Wong SL, Chao C, et al.: Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: A model for implementation of new surgical techniques. Ann Surg 2001;234:292-300.
6. Cody HS III: Sentinel lymph node biopsy for breast cancer: Does anybody not need one? Ann Surg Oncol 2003;10:1131-1132.
7. Cody HS, Klauber-DeMore N, Borgen PI, et al: Is it really DCIS? Ann Surg Oncol 2001;8:617-619.
8. Yen TW, Hunt KK, Ross MI, et al.: Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005;200:516-526.
9. Fisher B, Wolmark N, Banes M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Gynecol Obstet 1981;152:765-772.
10. Specht MC, Fey JV, Borgen PI, et al.: Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy? J Am Coll Surg 2005;200:10-14.
11. Krishnamurthy S, Sneige N, Bedi DG, et al.: Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002;95:982-988.
12. Stearns V, Ewing CA, Slack R, et al.: Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002;9:235-242.
13. Xing Y, Foy M, Cox DD, et al.: Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 2006;93:539-546.
14. Port ER, Fey J, Gemignani ML, et al.: Reoperative sentinel lymph node biopsy: A new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg 2002;195:167-172.
15. Giuliano AE: Z0010: A prognostic study of sentinel node and bone marrow micrometastases in women with clinical T1 or T2 N0 M0 breast cancer. Available from: http://www.acosog.org/studies/synopses/Z0010_Synopsis.pdf.
16. Krag DN: Protocol B-32: A randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer patients. http:www nsabppittedu/B-32htm 2003; Available from: http://www.nsabp.pitt.edu/B-32.htm.
17. EORTC 10981-22023 AMAROS trial. http://wwwamarosnl 2004.